Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
REGEnLIFE tests light stimulation on neurodegenerative diseases
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases

Neuroprotective effect of novel photobiomodulation technology reduces microbiota dysbiosis in the Aβ25-35 mouse model

Club Alzheimer de Montpellier (CALM) 2019, Montpellier

Laura Auboyer

Share this article